NEJM retracted the Tavneos ADVOCATE trial on June 29, 2026, after FDA found altered patient data. Patients should not stop Tavneos without a doctor — here’s what’s known.
Recent Posts
- Rocky Mountain Spotted Fever Can Kill Within 5 Days: Doctors Warn You Should Not Wait for the Rash
- The Northeast Heat Emergency Is Ending, but Flooding, Power Risk, and Dangerous Overnight Warmth Continue Today
- Michigan Has More Than 300 Cyclospora Cases and No Food Source Has Been Found
- The FDA Just Approved the First Inhaled Mealtime Insulin for Children
- The Clinical Trial That Supported Tavneos for ANCA Vasculitis Was Just Retracted
Archives
- July 2026
- June 2026
- May 2026
- February 2026
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- February 2024
- January 2024
- December 2023
- September 2023
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
Recent Comments